AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.
Unlock the market timeline & signal feed
New Product & Tech activity — 2 fresh signals just appeared.
The order this company entered each market — oldest to newest
District Manager
Remote/Virtual Sales Specialist (all genders)
Sign up to see the full signal feed
How AbbVie's international expansion compares to its competitors
AbbVieYouBars show relative size across the companies compared.
5 metrics| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 AbbVieYou | 56 | 1 | +39% | 966 | 34 |
Scaling fast — 1,803 roles opened in the last 90 days, up 157% vs the prior period. Engineering-led and concentrated in United States.
Guangzhou-Foshan Metropolitan Area · yesterday
District Manager
Shanghai, Shanghai, China · yesterday
Senior Statistician, Research
Hangzhou-Shaoxing Metropolitan Area · yesterday
Sr. Professional Medical Representative
45 technologies detected across the stack.
No campaigns running in this window.
45 mentions in the last 90 days.
CytomX Therapeutics will participate in three major healthcare investor conferences in September 2026, including Wells Fargo, Cantor Global, and Morgan Stanley events, with management available for investor meetings.
Celltrion announced a mid-to-long-term policy to allocate approximately 33% of annual net profit for shareholder returns, starting with a 100 billion won share buyback of 524,384 shares beginning September 1.
AbbVie's Allergan Aesthetics received NMPA approval for SKINVIVE (hyaluronic acid gel with lidocaine) to treat moderate-to-severe static perioral wrinkles in Chinese adults, backed by Phase III clinical trials.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about AbbVie's business, markets, and growth signals.
“We reach accounts the week they land in-market — not the quarter after.”
Book a walkthrough of the movement map with our team.
Pubrio turns expansion signals across 200+ markets into one live graph, so revenue teams see which companies are entering new markets, and act on the timing.
© 2026 Pubrio. All rights reserved.
